Adc Therapeutics SA (ADCT) SEC Filings — 2024

Filings

• Adc Therapeutics SA SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Adc Therapeutics SA SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• ADC Therapeutics SA Files 8-K on Shareholder Votes & Financials — 8-K · Nov 13, 2024
• ADC Therapeutics SA Files Q3 2024 10-Q Report — 10-Q · Nov 7, 2024
• ADC Therapeutics SA Files 2024 Proxy Statement — DEF 14A · Sep 23, 2024
• ADC Therapeutics SA Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
• ADC Therapeutics Sells Zynlonta Royalty Rights for $100M — 8-K · Jun 14, 2024
• ADC Therapeutics Sells Royalty Rights for $50M, Raises $100.1M — 8-K · May 14, 2024
• ADC Therapeutics Sells Zynlonta Royalty Rights for $50M — 8-K · May 8, 2024
• ADC Therapeutics SA Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
• Adc Therapeutics SA SC 13G Filing — SC 13G · May 3, 2024
• ADC Therapeutics SA Announces 2024 Annual General Meeting of Shareholders — DEF 14A · Apr 26, 2024
• ADC Therapeutics SA Files Proxy Statement — DEFA14A · Apr 26, 2024
• Auven Therapeutics Holdings LP Amends SC 13D Filing for ADC Therapeutics SA — SC 13D/A · Apr 25, 2024
• ADC Therapeutics Sells Zynlonta Royalty Rights for $100M — 8-K · Apr 9, 2024
• ADC Therapeutics SA Files 2023 Annual Report on Form 10-K — 10-K · Mar 13, 2024
• ADC Therapeutics Sells Zynlonta Royalty Rights for $50M — 8-K · Mar 5, 2024
• ADC Therapeutics Reports Officer Changes and Compensation Arrangements — 8-K · Feb 29, 2024
• Adc Therapeutics SA SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Adc Therapeutics SA SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• AstraZeneca Amends Passive Stake in ADC Therapeutics — SC 13G/A · Feb 12, 2024
• ADC Therapeutics Enters Material Definitive Agreement on Jan 18 — 8-K · Jan 24, 2024
• ADC Therapeutics Reports Undisclosed Material Agreement — 8-K · Jan 19, 2024
• ADC Therapeutics to Present at J.P. Morgan Healthcare Conference Jan 8 — 8-K · Jan 4, 2024